TO BE PUBLISHED April 2022
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference will examine developments in Long Covid research and treatment following the updated NICE guidelines for managing its long-term effects.
Delegates will discuss policy priorities for furthering clinical understanding, improving care provision, and supporting the health workforce.
It will also be an opportunity to discuss the implementation of the NHS Long Covid plan for 2021/22, how to utilise funding set out for the expansion of services, reducing variation, management of Long Covid within primary care, the future outlook for Long Covid research, and the impact of new NIHR-funded projects.
We are pleased to include keynote sessions with Professor Nick Lemoine, Chair, Long Covid Funding Committee and Medical Director, Clinical Research Network, NIHR; Dr Gail Allsopp, Clinical Lead for Clinical Policy, Royal College of General Practitioners; and Professor Brendan Delaney, Chair in Medical Informatics and Decision Making, Imperial College London.
Key areas for discussion include:
- the Long Covid Plan - delivery and the utilisation of allocated funding
- research - priority areas for further improving understanding of Long Covid and the effectiveness of services developed for the condition
- care pathways within ICS - leadership, implementation and commissioning, service development, rehabilitation, the impact of health inequalities, and integrating care
- Long Covid assessment clinics:
- assessing progress and what more is needed to improve accessibility and support referrals from primary care
- priorities for the development of services for children
- the health workforce - support, training and education priorities and sharing best practice in Long Covid care
- data - scaling up its use and improving understanding of Long Covid and its prevalence
- involving patients - the development of Long Covid services, driving awareness of expanded online support, and improving accessibility to information
The discussion is bringing together stakeholders with key policy officials who are due to attend from the DHSC; the Department of Health, NI; the DfT; the DWP; the FCDO; the Health and Safety Executive; HMRC; the MHRA; the NAO and the UK Health Security Agency - as well as parliamentary pass-holders from both Houses of Parliament and the Scottish Parliament.